Galderma Investigational Site 8215

Calgary, Alberta T3E 0B2

0 studies enrolling now · 3 studies all time

What they study most

Acne Vulgaris, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed
• Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris — Completed